fbpx

Tag Index  /  Showing 1 - 2 of 2 results for “Illumina”

Bio & Life Sciences Healthcare Society

Meeting My Genome: This Expensive Test Still Isn’t for Everyone

Earlier this year, I moderated a panel discussion at Techonomy Bio and asked speakers whether genome sequencing was ready for the average consumer. Their responses were split. Having now just gotten my own genome sequenced, I can say definitively: yes it’s ready, and no it isn’t.   More

Bio & Life Sciences Business

Can Hot Consumer Genomics Startup Helix Keep the FDA at Bay?

A new company launched by the market leader in DNA sequencing aims to bring genomics to the masses. Helix, kicked off on August 18 with a capital injection of more than $100 million, appears to embrace a direct-to-consumer approach that hasn’t been seen since pioneer 23andMe's ready-to-mail spit kits. Given the FDA’s firm pushback against 23andMe, though, does Helix has a bright future?   More